SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-062913
Filing Date
2023-11-13
Accepted
2023-11-13 16:05:42
Documents
56
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q annx-20230930.htm   iXBRL 10-Q 2690622
2 EX-31.1 annx-ex31_1.htm EX-31.1 18611
3 EX-31.2 annx-ex31_2.htm EX-31.2 18165
4 EX-32.1 annx-ex32_1.htm EX-32.1 17352
  Complete submission text file 0000950170-23-062913.txt   7801343

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT annx-20230930.xsd EX-101.SCH 40040
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT annx-20230930_lab.xml EX-101.LAB 367898
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT annx-20230930_def.xml EX-101.DEF 139238
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT annx-20230930_pre.xml EX-101.PRE 263811
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT annx-20230930_cal.xml EX-101.CAL 45313
50 EXTRACTED XBRL INSTANCE DOCUMENT annx-20230930_htm.xml XML 1271709
Mailing Address 1400 SIERRA POINT PARKWAY BLDG C, SUITE 200 BRISBANE CA 94005
Business Address 1400 SIERRA POINT PARKWAY BLDG C, SUITE 200 BRISBANE CA 94005 (650)-822-5500
Annexon, Inc. (Filer) CIK: 0001528115 (see all company filings)

IRS No.: 275414423 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39402 | Film No.: 231398597
SIC: 2834 Pharmaceutical Preparations